Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (56)
Jiabin Xu, Alexey Koval & Vladimir L. Katanaev. (2023) Clofazimine: A journey of a drug. Biomedicine & Pharmacotherapy 167, pages 115539.
Crossref
Crossref
Andrew R. Willmer, Jennifer Diaz-Espinosa, Austin Zhou, Kathleen A. Stringer & Gus R. Rosania. (2023) Distinguishing the Concentration- vs. Bioaccumulation-Dependent Immunological and Metabolic Effects of Clofazimine. Pharmaceutics 15:9, pages 2350.
Crossref
Crossref
Keita Yamanouchi, Tomoki Ishimaru, Takuya Kakuno, Yuki Takemoto, Sho Kawatsu, Keiji Kondo, Masato Maruyama & Kazutaka Higaki. (2023) Improvement and characterization of oral absorption behavior of clofazimine by SNEDDS: Quantitative evaluation of extensive lymphatic transport. European Journal of Pharmaceutics and Biopharmaceutics 187, pages 141-155.
Crossref
Crossref
Amy Lan Neusaenger, Xin Yao, Junguang Yu, Soojin Kim, Ho-Wah Hui, Lian Huang, Chailu Que & Lian Yu. (2023) Amorphous Drug–Polymer Salts: Maximizing Proton Transfer to Enhance Stability and Release. Molecular Pharmaceutics 20:2, pages 1347-1356.
Crossref
Crossref
Jacob A. M. Stadler, Gary Maartens, Graeme Meintjes & Sean Wasserman. (2023) Clofazimine for the treatment of tuberculosis. Frontiers in Pharmacology 14.
Crossref
Crossref
Ankit Ganeshpurkar, Ravi Singh, Meenakshi Singh, Ashok Kumar & Sushil Kumar Singh. 2023. Tuberculosis. Tuberculosis
541
569
.
Sisir Nandi, Mridula Saxena & Anil Kumar Saxena. 2023. Tuberculosis. Tuberculosis
429
457
.
Ashlee D. Brunaugh, Amanda Walz, Zachary Warnken, Camron Pearce, Juan Munoz Gutierrez, John J. Koleng, Hugh D. C. Smyth & Mercedes Gonzalez-Juarrero. (2022) Respirable Clofazimine Particles Produced by Air Jet Milling Technique Are Efficacious in Treatment of BALB/c Mice with Chronic Mycobacterium tuberculosis Infection. Antimicrobial Agents and Chemotherapy 66:9.
Crossref
Crossref
Kerstin Walter, Julia Kokesch-Himmelreich, Axel Treu, Franziska Waldow, Doris Hillemann, Nikolas Jakobs, Ann-Kathrin Lemm, Dominik Schwudke, Andreas Römpp & Christoph Hölscher. (2022) Interleukin-13-Overexpressing Mice Represent an Advanced Preclinical Model for Detecting the Distribution of Antimycobacterial Drugs within Centrally Necrotizing Granulomas. Antimicrobial Agents and Chemotherapy 66:6.
Crossref
Crossref
Sanghee Park, Jihee Jung, Jiyeon Kim, Sang Bong Han & Sungweon Ryoo. (2022) Investigation of Clofazimine Resistance and Genetic Mutations in Drug-Resistant Mycobacterium tuberculosis Isolates. Journal of Clinical Medicine 11:7, pages 1927.
Crossref
Crossref
Vipul K. Singh, Abhishek Mishra, Chinnaswamy Jagannath & Arshad Khan. 2022. Herbal Medicines. Herbal Medicines
453
471
.
J. Casper, S. Mohammad-Khani, J. J. Schmidt, J. T. Kielstein, T. Lenarz, H. Haller & Annette D. Wagner. (2021) Melkersson–Rosenthal syndrome in the context of sarcoidosis: a case report . Journal of Medical Case Reports 15:1.
Crossref
Crossref
Andrzej Błauż, Błażej Rychlik, Damian Plazuk, Francesca Peccati, Gonzalo Jiménez-Osés, Urszula Steinke, Malgorzata Sierant, Katarzyna Trzeciak, Ewa Skorupska & Beata Miksa. (2021) Biotin-phenosafranin as a new photosensitive conjugate for targeted therapy and imaging. New Journal of Chemistry 45:21, pages 9691-9702.
Crossref
Crossref
Ameya D. Bendre, Peter J. Peters & Janesh Kumar. (2021) Tuberculosis: Past, present and future of the treatment and drug discovery research. Current Research in Pharmacology and Drug Discovery 2, pages 100037.
Crossref
Crossref
Vladimir L. Katanaev, Artem Blagodatski, Jiabin Xu, Yuri Khotimchenko & Alexey Koval. 2021. Pharmacology of the WNT Signaling System. Pharmacology of the WNT Signaling System
215
248
.
Mpelegeng Victoria Bvumbi. (2020)
Activity of Riminophenazines against
Mycobacterium tuberculosis
: A Review of Studies that Might be Contenders for Use as Antituberculosis Agents
. ChemMedChem 15:23, pages 2207-2219.
Crossref
Crossref
Tom G Jacobs, Elin M Svensson, Victor Musiime, Pablo Rojo, Kelly E Dooley, Helen McIlleron, Rob E Aarnoutse, David M Burger, Anna Turkova, Angela Colbers, Elaine Abrams, Moherndran Archary, Yodit Belew, Brookie Best, David Burger, Jessica Burry, Edmund Capparelli, Deborah Carpenter, Esther Casas, Polly Clayden, Diana Clarke, Tim Cressey, Angela Colbers, Mutsa Dangarembizi, Paolo Denti, Karim Diop, Andrea Ecker, Shaffiq Essajee, Carlo Giaquinto, Diana Gibb, Rohan Hazra, Maria Kim, Marc Lallemant, Janice Lee, Linda Lewis, Shahin Lockman, Mark Mirochnick, Lynne Mofenson, Victor Musiime, Elizabeth Obimbo, Atieno Ojoo, Fernando Pascual, Martina Penazzato, Jorge Pinto, Natella Rakhmanina, Pablo Rojo, Ted Ruel, George Siberry, Nandita Sugandhi, Anna Turkova, Marissa Vicari, Melynda Watkins & Hilary Wolf. (2020) Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic review. Journal of Antimicrobial Chemotherapy 75:12, pages 3433-3457.
Crossref
Crossref
Mahmoud Tareq Abdelwahab, Sean Wasserman, James C M Brust, Neel R Gandhi, Graeme Meintjes, Daniel Everitt, Andreas Diacon, Rodney Dawson, Lubbe Wiesner, Elin M Svensson, Gary Maartens & Paolo Denti. (2020) Clofazimine pharmacokinetics in patients with TB: dosing implications. Journal of Antimicrobial Chemotherapy 75:11, pages 3269-3277.
Crossref
Crossref
Joseph George. (2020) Metabolism and interactions of antileprosy drugs. Biochemical Pharmacology 177, pages 113993.
Crossref
Crossref
Tingting Zhang, Wanting Yin, Bo Jin, Tong Li & Chen Ma. (2020) A reliable HPLC-DAD method for simultaneous determination of related substances in TBI-166 active pharmaceutical ingredient. Acta Chromatographica 32:2, pages 80-85.
Crossref
Crossref
Russell R. Kempker, Wael A. Alghamdi, Mohammad H. Al-Shaer, Gena Burch & Charles A. Peloquin. (2019) A Pharmacology Perspective on Simultaneous Tuberculosis and Hepatitis C Treatment. Antimicrobial Agents and Chemotherapy 63:12.
Crossref
Crossref
Lorenzo Angiolini, Boiko Cohen & Abderrazzak Douhal. (2019) Single Crystal FLIM Characterization of Clofazimine Loaded in Silica-Based Mesoporous Materials and Zeolites. International Journal of Molecular Sciences 20:12, pages 2859.
Crossref
Crossref
Chiara Piotto & Paolo Bettotti. (2019) Surfactant mediated clofazimine release from nanocellulose-hydrogels. Cellulose 26:7, pages 4579-4587.
Crossref
Crossref
Jitendra Wankar, Francesca Bonvicini, Gabor Benkovics, Valentina Marassi, Milo Malanga, Eva Fenyvesi, Giovanna Angela Gentilomi, Pierluigi Reschiglian, Barbara Roda & Ilse Manet. (2018)
Widening the Therapeutic Perspectives of Clofazimine by Its Loading in Sulfobutylether β-Cyclodextrin Nanocarriers: Nanomolar IC
50
Values against MDR
S. epidermidis
. Molecular Pharmaceutics 15:9, pages 3823-3836.
Crossref
Crossref
Nicole C. Ammerman, Rosemary V. Swanson, Elaine M. Bautista, Deepak V. Almeida, Vikram Saini, Till F. Omansen, Haidan Guo, Yong Seok Chang, Si-Yang Li, Asa Tapley, Rokeya Tasneen, Sandeep Tyagi, Fabrice Betoudji, Chivonne Moodley, Bongani Ngcobo, Logan Pillay, Linda A. Bester, Sanil D. Singh, Richard E. Chaisson, Eric Nuermberger & Jacques H. Grosset. (2018) Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis. Antimicrobial Agents and Chemotherapy 62:7.
Crossref
Crossref
Zubair Shanib Bhat, Muzafar Ahmad Rather, Mubashir Maqbool & Zahoor Ahmad. (2018) Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon. Biomedicine & Pharmacotherapy 103, pages 1733-1747.
Crossref
Crossref
Iram Iqbal, Sapna Bajeli, Ajit Akela & Ashwani Kumar. (2018) Bioenergetics of Mycobacterium: An Emerging Landscape for Drug Discovery. Pathogens 7:1, pages 24.
Crossref
Crossref
Tehetina Woldemichael, Rahul K. Keswani, Phillip M. Rzeczycki, Mikhail D. Murashov, Vernon LaLone, Brian Gregorka, Joel A. Swanson, Kathleen A. Stringer & Gus R. Rosania. (2018) Reverse Engineering the Intracellular Self-Assembly of a Functional Mechanopharmaceutical Device. Scientific Reports 8:1.
Crossref
Crossref
Lorenzo Angiolini, Sabrina Valetti, Boiko Cohen, Adam Feiler & Abderrazzak Douhal. (2018) Fluorescence imaging of antibiotic clofazimine encapsulated within mesoporous silica particle carriers: relevance to drug delivery and the effect on its release kinetics. Physical Chemistry Chemical Physics 20:17, pages 11899-11911.
Crossref
Crossref
Yingyue Zhang, Jie Feng, Simon A. McManus, Hoang D. Lu, Kurt D. Ristroph, Eugene J. Cho, Ellen L. Dobrijevic, Hak-Kim Chan & Robert K. Prud’homme. (2017) Design and Solidification of Fast-Releasing Clofazimine Nanoparticles for Treatment of Cryptosporidiosis. Molecular Pharmaceutics 14:10, pages 3480-3488.
Crossref
Crossref
Sabrina Valetti, Xin Xia, Joana Costa-Gouveia, Priscille Brodin, Marie-Françoise Bernet-Camard, Margareta Andersson & Adam Feiler. (2017)
Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant
Mycobacterium tuberculosis
infections
. Nanomedicine 12:8, pages 831-844.
Crossref
Crossref
Diana Quan, Gayathri Nagalingam, Richard Payne & James A. Triccas. (2017) New tuberculosis drug leads from naturally occurring compounds. International Journal of Infectious Diseases 56, pages 212-220.
Crossref
Crossref
Thomas M. Reeves, Patricia A. Trimmer, Beverly S. Colley & Linda L. Phillips. (2016) Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury. Experimental Neurology 283, pages 188-203.
Crossref
Crossref
Kamal Ahmed, Holly Shaw, Alexey Koval & Vladimir Katanaev. (2016) A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers. Cancers 8:7, pages 66.
Crossref
Crossref
Rahul K. Keswani, Chao Tian, Tyler Peryea, Gandikota Girish, Xueding Wang & Gus R. Rosania. (2016) Repositioning Clofazimine as a Macrophage-Targeting Photoacoustic Contrast Agent. Scientific Reports 6:1.
Crossref
Crossref
Shengke Li, Judy Yuet-Wa Chan, Yan Li, David Bardelang, Jun Zheng, Wing Wai Yew, Denise Pui-Chung Chan, Simon Ming Yuen Lee & Ruibing Wang. (2016) Complexation of clofazimine by macrocyclic cucurbit[7]uril reduced its cardiotoxicity without affecting the antimycobacterial efficacy. Organic & Biomolecular Chemistry 14:31, pages 7563-7569.
Crossref
Crossref
Rahul K. Keswani, Gi S. Yoon, Sudha Sud, Kathleen A. Stringer & Gus R. Rosania. (2015) A far-red fluorescent probe for flow cytometry and image-based functional studies of xenobiotic sequestering macrophages. Cytometry Part A 87:9, pages 855-867.
Crossref
Crossref
Rahul K. Keswani, Jason Baik, Larisa Yeomans, Chuck Hitzman, Allison M. Johnson, Ashtamurthy S. Pawate, Paul J. A. Kenis, Nair Rodriguez-Hornedo, Kathleen A. Stringer & Gus R. Rosania. (2015) Chemical Analysis of Drug Biocrystals: A Role for Counterion Transport Pathways in Intracellular Drug Disposition. Molecular Pharmaceutics 12:7, pages 2528-2536.
Crossref
Crossref
Dan Li, Li Sheng, Xin Liu, Shuang Yang, Zhihao Liu & Yan Li. (2014) Determination of TBI-166, a Novel Antituberculotic, in Rat Plasma by Liquid Chromatography–Tandem Mass Spectrometry. Chromatographia 77:23-24, pages 1697-1703.
Crossref
Crossref
Yasuhiro Horita & Norio Doi. (2014) Comparative Study of the Effects of Antituberculosis Drugs and Antiretroviral Drugs on Cytochrome P450 3A4 and P-Glycoprotein. Antimicrobial Agents and Chemotherapy 58:6, pages 3168-3176.
Crossref
Crossref
Cheruvu Hanumanth Srikanth, Pankaj Joshi, Anil Kumar Bikkasani, Konica Porwal & Jiaur R. Gayen. (2014) Bone distribution study of anti leprotic drug clofazimine in rat bone marrow cells by a sensitive reverse phase liquid chromatography method. Journal of Chromatography B 960, pages 82-86.
Crossref
Crossref
Dongfeng Zhang, Yang Liu, Chunlin Zhang, Hao Zhang, Bin Wang, Jian Xu, Lei Fu, Dali Yin, Christopher Cooper, Zhenkun Ma, Yu Lu & Haihong Huang. (2014) Synthesis and Biological Evaluation of Novel 2-Methoxypyridylamino-Substituted Riminophenazine Derivatives as Antituberculosis Agents. Molecules 19:4, pages 4380-4394.
Crossref
Crossref
A.V. Koval, P. Vlasov, P. Shichkova, S. Khunderyakova, Y. Markov, J. Panchenko, A. Volodina, F.A. Kondrashov & V.L. Katanaev. (2014) Anti-leprosy drug clofazimine inhibits growth of triple-negative breast cancer cells via inhibition of canonical Wnt signaling. Biochemical Pharmacology 87:4, pages 571-578.
Crossref
Crossref
Jason Baik, Kathleen A. Stringer, Gerta Mane & Gus R. Rosania. (2013) Multiscale Distribution and Bioaccumulation Analysis of Clofazimine Reveals a Massive Immune System-Mediated Xenobiotic Sequestration Response. Antimicrobial Agents and Chemotherapy 57:3, pages 1218-1230.
Crossref
Crossref
Dongfeng Zhang, Yu Lu, Kai Liu, Binna Liu, Jingbin Wang, Gang Zhang, Hao Zhang, Yang Liu, Bin Wang, Meiqin Zheng, Lei Fu, Yanyan Hou, Ningbo Gong, Yang Lv, Chun Li, Christopher B. Cooper, Anna M. Upton, Dali Yin, Zhenkun Ma & Haihong Huang. (2012) Identification of Less Lipophilic Riminophenazine Derivatives for the Treatment of Drug-Resistant Tuberculosis. Journal of Medicinal Chemistry 55:19, pages 8409-8417.
Crossref
Crossref
Ujjini Manjunatha*Fumiaki Yokokawa, Meera Gurumurthy & Thomas Dick. 2012. Drug Discovery from Natural Products. Drug Discovery from Natural Products
307
325
.
Juan M. Pallicer, Carme Calvet, Adriana Port, Martí Rosés, Clara Ràfols & Elisabeth Bosch. (2012) Extension of the liquid chromatography/quantitative structure–property relationship method to assess the lipophilicity of neutral, acidic, basic and amphotheric drugs. Journal of Chromatography A 1240, pages 113-122.
Crossref
Crossref
Binna Liu, Kai Liu, Yu Lu, Dongfeng Zhang, Tianming Yang, Xuan Li, Chen Ma, Meiqin Zheng, Bin Wang, Gang Zhang, Fei Wang, Zhenkun Ma, Chun Li, Haihong Huang & Dali Yin. (2012) Systematic Evaluation of Structure-Activity Relationships of the Riminophenazine Class and Discovery of a C2 Pyridylamino Series for the Treatment of Multidrug-Resistant Tuberculosis. Molecules 17:4, pages 4545-4559.
Crossref
Crossref
M. C. Cholo, H. C. Steel, P. B. Fourie, W. A. Germishuizen & R. Anderson. (2011) Clofazimine: current status and future prospects. Journal of Antimicrobial Chemotherapy 67:2, pages 290-298.
Crossref
Crossref
Daniela Weeken & Martin Schlitzer. (2012)
Wirkstoffe gegen
Mycobacterium tuberculosis
in klinischer Anwendung
. Pharmazie in unserer Zeit 41:1, pages 35-47.
Crossref
Crossref
Jason Baik & Gus R. Rosania. (2011) Molecular Imaging of Intracellular Drug–Membrane Aggregate Formation. Molecular Pharmaceutics 8:5, pages 1742-1749.
Crossref
Crossref
Takahiro Yano, Sacha Kassovska-Bratinova, J. Shin Teh, Jeffrey Winkler, Kevin Sullivan, Andre Isaacs, Norman M. Schechter & Harvey Rubin. (2011) Reduction of Clofazimine by Mycobacterial Type 2 NADH:Quinone Oxidoreductase. Journal of Biological Chemistry 286:12, pages 10276-10287.
Crossref
Crossref
Mohammad H Pourgholami, Ying Lu, Lisa Wang, Ross W Stephens & David L Morris. (2004) Regression of Novikoff rat hepatocellular carcinoma following locoregional administration of a novel formulation of clofazimine in lipiodol. Cancer Letters 207:1, pages 37-47.
Crossref
Crossref
David E. Nix, Rodney D. Adam, Barbara Auclair, Todd S. Krueger, Paul G. Godo & Charles A. Peloquin. (2004) Pharmacokinetics and relative bioavailability of clofazimine in relation to food, orange juice and antacid. Tuberculosis 84:6, pages 365-373.
Crossref
Crossref
C.E.J. Van Rensburg, R. Anderson & J.F. O'Sullivan. (1997) Riminophenazine compounds: pharmacology and anti-neoplastic potential. Critical Reviews in Oncology/Hematology 25:1, pages 55-67.
Crossref
Crossref
Robert O'Connor, J.F. O'Sullivan & Richard O'Kennedy. (1996) Determination of serum and tissue levels of phenazines including clofazimine. Journal of Chromatography B: Biomedical Sciences and Applications 681:2, pages 307-315.
Crossref
Crossref